Close relationship between sympathetic activation and coronary microvascular dysfunction during acute hyperglycemia in subjects with atherosclerotic risk factors

Circulation Journal

Volumn 71, Issue 2, 2007, Pages 202-206

  Takei, Yasuyoshi ^a   Tomiyama, Hirofumi ^a   Tanaka, Nobuhiro ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Hyperglycemia; Oxidative stress; Sympathetic nervous system

Indexed keywords

ADENOSINE; THIOBARBITURIC ACID;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOPPLER ECHOCARDIOGRAPHY; HEART RATE VARIABILITY; HUMAN; HYPERGLYCEMIA; MICROANGIOPATHY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; SYMPATHETIC TONE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; AGED; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; HYPERGLYCEMIA; LINEAR MODELS; MALE; MICROCIRCULATION; MIDDLE AGED; OXIDATIVE STRESS; REGIONAL BLOOD FLOW; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33846578357     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.202     Document Type: Article

References (41)

1. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: The Framingham Offspring Study. Diabetes Care 2002; 25: 1845-1850.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-778.
3. Kosuge M, Kimura K, Kojima S, Sakamoto T, Matsui K, Ishihara M, et al; Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction. Circ J 2005; 69: 375-379.
4. Ishii H, Ichimiya S, Kanashiro M, Amano T, Matsubara T, Murohara T. Effects of intravenous nicorandil before reperfusion for acute myocardial infarction in patients with stress hyperglycemia. Diabetes Care 2006; 29: 202-206.
5. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001; 103: 1618-1623.
6. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
7. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093-2098.
8. Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG. Coronary heart disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000; 102: 1233-1238.
9. Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, et al. Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44: 2368-2374.
10. Dimitrow PP, Galderisi M, Rigo F. The non-invasive documentation of coronary microcirculation impairment: Role of transthoracic echocardiography. Cardiovasc Ultrasound 2005; 3: 18-19.
11. Hirata K, Amudha K, Elina R, Hozumi T, Yoshikawa J, Homma S, et al. Measurement of coronary vasomotor function: Getting to the heart of the matter in cardiovascular research. Clin Sci (Lond) 2004; 107: 449-460.
12. Miyazaki C, Takeuchi M, Yoshitani H, Otani S, Sakamoto K, Yoshikawa J. Optimum hypoglycemic therapy can improve coronary flow velocity reserve in diabetic patients: Demonstration by transthoracic doppler echocardiography. Circ J 2003; 67: 945-950.
13. Hasegawa R, Daimon M, Toyoda T, Teramoto K, Sekine T, Kawata T, et al. Effect of mental stress on coronary flow velocity reserve in healthy men. Am J Cardiol 2005; 96: 137-140.
14. Teramoto K, Daimon M, Hasegawa R, Toyoda T, Sekine T, Kawata T, et al. Acute effect of oral vitamin C on coronary circulation in young healthy smokers. Am Heart J 2004; 148: 300-305.
15. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: Strengths and limitations. Free Radic Biol Med 2000; 28: 1745-1750.
16. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005; 39: 841-852.
17. Nakao M, Nomura K, Karita K, Nishikitani M, Yano E. Relationship between brachial-ankle pulse wave velocity and heart rate variability in young Japanese men. Hypertens Res 2004; 27: 925-931.
18. Tateishi O, Shouda T, Azuma Y, Chin K, Nogimura T, Gotou Y, et al. Heart rate variability in congestive heart failure. Clin Exp Hypertens 2002; 24: 75-81.
19. Tomiyama H, Nakayama T, Watanabe G, Shiojima K, Sakuma Y, Yamamoto A, et al. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 1999; 137: 543-548.
20. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva, WHO, 1999.
21. Smits SB, Williams DE, Lipson P, Banitt GA, Rongen Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995; 92: 2135-2141.
22. Zeiher AM, Drexler H, Wollschläger H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-1992.
23. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 1998; 47: 119-124.
24. Prior JO, Quinones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005; 111: 2291-2298.
25. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003; 41: 1387-1393.
26. Capaldo B, Galderisi M, Turco AA, D'Errico A, Turco S, Rivellese AA, et al. Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. J Clin Endocrinol Metab 2005; 90: 3871-3876.
27. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2005; 112: 179-184.
28. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003; 108: 1527-1532.
29. Ceriello A. Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia. Am Heart J 2004; 147: 803-807.
30. Yamashita K, Tasaki H, Nagai Y, Suzuka H, Nihei S, Kobayashi K, et al. Experimental hyperhomocysteinemia impairs coronary flow velocity reserve. Int J Cardiol 2005; 104: 163-169.
31. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
32. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 2001; 108: 635-636.
33. Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, et al. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol 2001; 38: 1821-1828.
34. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Re 2004; 25: 543-567.
35. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al; Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004; 27: 1954-1961.
36. Hoffman RP, Hausberg M, Sinkey CA, Anderson EA. Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Diabetes Complications 1999; 13: 17-22.
37. Van De Borne P, Hausberg M, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and non-uniform sympathetic activation in normal subjects. Am J Physiol 1999; 276(1 Pt 2): R178-R183.
38. Ye S, Zhong H, Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 2006; 48: 309-315.
39. Fiegel EO. Neural control of coronary blood flow. J Vasc Res 1998; 35: 85-92.
40. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19(Suppl F): F62-F71.
41. Srinivasan M, Herrero P, McGill JB, Bennik J, Heere B, Lesniak D, et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 2005; 46: 42-48.